Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Urologists should screen for mental health issues before and during finasteride treatment.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

CT scans can find serious prostate cancer even when PSA levels are low.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Finasteride treats hair loss and reduces prostate cancer risk.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Finasteride helps reduce heart issues and improves heart function.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

The PW91 method is best for calculating the basic physical and chemical properties of Finasteride, a drug used for prostate issues and hair loss.